Soligenix (SNGX)

Enteron Pharmaceuticals, Inc. • Orasomal Technologies Inc. • Soligenix BioPharma Canada Incorporated • Soligenix UK Limited • Soligenix NE B.V. • Soligenix Biopharma HI, Inc. ...

IRS number

411505029

SNGX stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Prospectus supplement for primary offering

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

18 Nov 25

424B3

Prospectus supplement

7 Nov 25

424B3

Prospectus supplement

7 Nov 25

424B3

Prospectus supplement

7 Nov 25

Soligenix Announces Pricing of $7.5 Million Public Offering

29 Sep 25

424B4

Prospectus supplement with pricing info

26 Sep 25

Latest ownership filings

View all

CHRISTOPHER J SCHABER

CHRISTOPHER J SCHABER

ANTHONY GREGG LAPOINTE

Financial summary

Financial statements Chart SNGX financial data

Quarter (USD)	Sep 25	Jun 25	Mar 25	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.53 mm	10.53 mm	10.53 mm	10.53 mm	10.53 mm	10.53 mm
Cash burn (monthly)	(no burn)	(no burn)	860.16 k	1.02 mm	977.54 k	812.86 k
Cash used (since last report)	n/a	n/a	3.87 mm	4.60 mm	4.39 mm	3.65 mm
Cash remaining	n/a	n/a	6.66 mm	5.92 mm	6.13 mm	6.87 mm
Runway (months of cash)	n/a	n/a	7.7	5.8	6.3	8.5

Beta Read what these cash burn values mean

Financial data from Soligenix earnings reports.

Institutional ownership, Q3 2024

SNGX institutional ownership history Ownership history

6.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	4	-50.0%
Opened positions	0	3	EXIT
Closed positions	2	0	NEW
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	1.06 mm	26.86 mm	-96.1%
Total shares	678.34 k	688.34 k	-1.5%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Altamont Phamaceutical	678.34 k	$1.05 mm	0.0%
Albion Financial	1.00	$4.00 k	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
ONB Old National Bancorp	0.00	-10.00 k	EXIT
Trust Co Of Vermont	0.00	-1.00	EXIT
Proequities	0.00	0.00
Albion Financial	1.00	0.00	0.0%
Altamont Phamaceutical	678.34 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SNGX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
11 Dec 25	Jonathan L. Guarino	Option Common Stock	Grant	Acquire A	No	No	1.63	100,000	163.00 k	100,000
11 Dec 25	Christopher J Schaber	Option Common Stock	Grant	Acquire A	No	No	1.63	200,000	326.00 k	200,000
11 Dec 25	Richard Straube	Option Common Stock	Grant	Acquire A	No	No	1.63	10,000	16.30 k	10,000
11 Dec 25	Oreola Donini	Option Common Stock	Grant	Acquire A	No	No	1.63	100,000	163.00 k	100,000
2 Oct 25	Christopher J Schaber	Common Stock	Buy	Acquire P	No	No	1.3217	15,132	20.00 k	15,511

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.